A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancer.

Guy Berchem*, Sigrid Dewilde, Philippe Mahassen

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

We report the case of a 78-year-old man diagnosed with metastatic renal cell carcinoma developping acute haemolysis under Sunitinib as well as under Sorafenib. This side effect induced a definitive withdrawal from the drugs. As these drugs are used more widely, rare side effects are bound to appear.

Original languageEnglish
Pages (from-to)7-9
Number of pages3
JournalBulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg
Issue number1
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancer.'. Together they form a unique fingerprint.

Cite this